Chilton Capital Management LLC Decreased Stake in Cvs Health Corp (CVS) by $5.36 Million as Market Valuation Declined

July 18, 2017 - By Peter Erickson

Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.24, from 0.98 in 2016Q3. It dropped, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Gabelli Funds Ltd Llc holds 0.67% of its portfolio in CVS Health Corp (NYSE:CVS) for 1.43 million shares. Guggenheim Cap Ltd Llc has invested 0.26% in CVS Health Corp (NYSE:CVS). Greenwood Gearhart reported 0.9% of its portfolio in CVS Health Corp (NYSE:CVS). Illinois-based Vaughan David Inc Il has invested 0.8% in CVS Health Corp (NYSE:CVS). Hartford Financial Mgmt Incorporated reported 2.72% of its portfolio in CVS Health Corp (NYSE:CVS). Wellington Gp Llp holds 0.39% or 19.57M shares. Hayek Kallen Investment Mngmt stated it has 0.78% of its portfolio in CVS Health Corp (NYSE:CVS). Toronto Dominion Bancorp has 0.06% invested in CVS Health Corp (NYSE:CVS). Todd Asset Management Lc has 234,626 shares for 0.56% of their portfolio. 19,952 are held by Advisor Partners Limited Liability Corp. Whittier Of Nevada Inc holds 0.46% or 55,286 shares in its portfolio. New Jersey-based Private Advisor Ltd Liability Company has invested 0.11% in CVS Health Corp (NYSE:CVS). State Of Wisconsin Invest Board stated it has 1.30 million shares or 0.44% of all its holdings. Pacad Invest has 0.74% invested in CVS Health Corp (NYSE:CVS) for 74,631 shares. Richard Bernstein Advsr Limited Liability has invested 0.06% in CVS Health Corp (NYSE:CVS).

Since February 1, 2017, it had 0 insider purchases, and 7 sales for $40.53 million activity. 14,104 shares were sold by Sussman Andrew, worth $1.13 million on Monday, March 13. 230,510 shares were sold by Denton David M, worth $18.44 million. Boratto Eva C had sold 6,029 shares worth $479,908. Shares for $1.88M were sold by Brennan Troyen A. Shares for $5.99M were sold by MERLO LARRY J on Wednesday, February 1. 61,196 CVS Health Corp (NYSE:CVS) shares with value of $4.90 million were sold by Roberts Jonathan C.

Chilton Capital Management Llc decreased its stake in Cvs Health Corp (CVS) by 39.31% based on its latest 2016Q4 regulatory filing with the SEC. Chilton Capital Management Llc sold 68,780 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 106,206 shares of the medical and nursing services company at the end of 2016Q4, valued at $8.38 million, down from 174,986 at the end of the previous reported quarter. Chilton Capital Management Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $80.15 billion market cap company. The stock increased 0.47% or $0.37 on July 17, reaching $78.3. About shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since July 18, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Analysts expect CVS Health Corp (NYSE:CVS) to report $1.31 EPS on August, 1.They anticipate $0.01 EPS change or 0.76 % from last quarter’s $1.32 EPS. CVS’s profit would be $1.34 billion giving it 14.94 P/E if the $1.31 EPS is correct. After having $1.17 EPS previously, CVS Health Corp’s analysts see 11.97 % EPS growth.

More notable recent CVS Health Corp (NYSE:CVS) news were published by: Investorplace.com which released: “Why CVS Health Corp (CVS) Stock Will Win BIG With Trumpcare” on June 23, 2017, also Gurufocus.com with their article: “CVS Health and Valero Look Good by This Measure” published on July 17, 2017, Zacks.com published: “CVS Health’s MinuteClinic Joins EOHN for Workplace Healthcare” on July 12, 2017. More interesting news about CVS Health Corp (NYSE:CVS) were released by: Reuters.com and their article: “CVS to pay $5 million to resolve US drug probe” published on July 11, 2017 as well as Fool.com‘s news article titled: “How CVS Health Corporation Makes Most of Its Money” with publication date: June 30, 2017.

CVS Health Corp (NYSE:CVS) Ratings Coverage

Among 21 analysts covering CVS Health (NYSE:CVS), 13 have Buy rating, 0 Sell and 8 Hold. Therefore 62% are positive. CVS Health has $132 highest and $77 lowest target. $107.59’s average target is 37.41% above currents $78.3 stock price. CVS Health had 32 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corp (NYSE:CVS) has “Neutral” rating given on Thursday, February 2 by Robert W. Baird. The stock has “Buy” rating by Vetr on Monday, August 24. Evercore reinitiated the stock with “Buy” rating in Wednesday, August 19 report. The stock of CVS Health Corp (NYSE:CVS) has “Buy” rating given on Thursday, May 12 by Jefferies. Deutsche Bank maintained the shares of CVS in report on Wednesday, July 22 with “Hold” rating. On Friday, April 28 the stock rating was initiated by Tigress Financial with “Buy”. Argus Research maintained it with “Buy” rating and $118.0 target in Monday, August 10 report. Deutsche Bank maintained the stock with “Hold” rating in Thursday, August 20 report. The company was maintained on Monday, May 9 by Citigroup. The rating was initiated by UBS on Thursday, October 6 with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.